IFITM2 and IFITM3 Restrict Toxoplasma gondii Proliferation and Modulate Host Immune Responses
Cells · 14.11.2026 · 15 (22) · 2085
DOI: 10.3390/cells15222085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 14.11.2026. Verfasst von Yanlong Gu und 3 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Special Fund for Science and Technology Innovation of Fujian Agriculture and Forestry University, Fujian Province Modern Poultry Industry Technology System Construction Project, Key Laboratory for Diagnosis and Treatment of Zoonotic Infectious Diseases—Open Fund.
Abstract (Originalsprache)
Toxoplasma gondii is a widespread intracellular parasite that causes severe disease in humans and animals. Interferon-induced transmembrane proteins (IFITMs) are critical interferon-stimulated genes (ISGs) with broad antiviral functions, but their role during T. gondii infection remains unknown. In this study, we examined the expression and phosphorylation status of STAT1 alongside IFITM2/IFITM3 levels in T. gondii-infected Vero cells and mice using Western blotting (WB) and real-time quantitative PCR (RT-qPCR). Additionally, exogenous overexpression and knockdown experiments were performed by constructing IFITM2/IFITM3 overexpression vectors and small interfering RNAs (siRNAs), respectively. Intracellular T. gondii parasite burden was quantified using absolute quantitative PCR. Finally, differentially expressed genes were identified via transcriptome sequencing (RNA-Seq) using cells with IFITM2/IFITM3 overexpression or knockdown followed by T. gondii infection. In both in vivo and in vitro models of T. gondii infection, reduced STAT1 phosphorylation and decreased IFITM2 and IFITM3 expression were observed during infection. These findings represent parallel infection-associated changes; however, the present study did not directly manipulate IFN-γ or STAT1 signaling and therefore does not establish a mechanistic relationship between STAT1 phosphorylation and IFITM2/3 expression. Exogenous overexpression of IFITM2 and IFITM3 correlates with reduced intracellular T. gondii parasite burden, whereas siRNA-mediated knockdown of these proteins leads to increased parasite load. Transcriptomic profiling identified differentially expressed genes enriched in immune and other pathways (such as IL37, TRIM22, IL12A, and FOXC2). These transcriptomic alterations provide preliminary candidate pathways for future mechanistic investigations. In mice, temporal changes in IFITM2/3 expression were observed alongside changes in parasite burden during T. gondii infection. In Vero cells, functional manipulation of IFITM2/3 through overexpression or knockdown altered intracellular parasite burden, supporting a cell-autonomous association between IFITM2/3 expression and cumulative intracellular parasite burden. However, the functional role of IFITM2/3 in vivo remains to be established, and the precise stages of the parasite life cycle affected by IFITM2/3 remain to be determined. These findings provide an initial basis for understanding the potential role of IFITM2/3 in cellular innate defense and may inform future investigations.
Förderung
- Special Fund for Science and Technology Innovation of Fujian Agriculture and Forestry University
- Fujian Province Modern Poultry Industry Technology System Construction Project
- Key Laboratory for Diagnosis and Treatment of Zoonotic Infectious Diseases—Open Fund
Zitieren
APA
Gu, Y., Chu, M., Li, S., & Zhou, D. (2026). IFITM2 and IFITM3 Restrict Toxoplasma gondii Proliferation and Modulate Host Immune Responses. Cells, 15(22), 2085. https://doi.org/10.3390/cells15222085
Vancouver
Gu Y, Chu M, Li S, Zhou D. IFITM2 and IFITM3 Restrict Toxoplasma gondii Proliferation and Modulate Host Immune Responses. Cells. 2026;15(22):2085. doi:10.3390/cells15222085
BibTeX
@article{Gu2026,
author = {Gu, Yanlong and Chu, Meng-Jie and Li, Si-Ang and Zhou, Dong-Hui},
title = {IFITM2 and IFITM3 Restrict Toxoplasma gondii Proliferation and Modulate Host Immune Responses},
journal = {Cells},
year = {2026},
volume = {15},
number = {22},
pages = {2085},
doi = {10.3390/cells15222085}
}
EUVIMED